KR20190119774A - Method for manufacturing transparent water comprising heat-killed lactic acid bacteria - Google Patents
Method for manufacturing transparent water comprising heat-killed lactic acid bacteria Download PDFInfo
- Publication number
- KR20190119774A KR20190119774A KR1020180043144A KR20180043144A KR20190119774A KR 20190119774 A KR20190119774 A KR 20190119774A KR 1020180043144 A KR1020180043144 A KR 1020180043144A KR 20180043144 A KR20180043144 A KR 20180043144A KR 20190119774 A KR20190119774 A KR 20190119774A
- Authority
- KR
- South Korea
- Prior art keywords
- lactic acid
- acid bacteria
- emulsion
- bottled water
- water containing
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 116
- 241000894006 Bacteria Species 0.000 title claims abstract description 58
- 239000004310 lactic acid Substances 0.000 title claims abstract description 58
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 58
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims abstract description 19
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 14
- 241000194032 Enterococcus faecalis Species 0.000 claims abstract description 13
- 229940032049 enterococcus faecalis Drugs 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 239000000839 emulsion Substances 0.000 claims description 38
- 244000005700 microbiome Species 0.000 claims description 33
- 235000013361 beverage Nutrition 0.000 claims description 25
- 235000012206 bottled water Nutrition 0.000 claims description 17
- 239000003996 polyglycerol polyricinoleate Substances 0.000 claims description 16
- 235000010958 polyglycerol polyricinoleate Nutrition 0.000 claims description 16
- 239000012895 dilution Substances 0.000 claims description 15
- 238000010790 dilution Methods 0.000 claims description 15
- 239000012153 distilled water Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 11
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 claims description 6
- 239000004698 Polyethylene Substances 0.000 claims description 6
- -1 polyethylene Polymers 0.000 claims description 6
- 229920000573 polyethylene Polymers 0.000 claims description 6
- 229940035044 sorbitan monolaurate Drugs 0.000 claims description 6
- 238000007865 diluting Methods 0.000 claims description 4
- 238000000265 homogenisation Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 125000005456 glyceride group Chemical group 0.000 claims description 3
- 229940057917 medium chain triglycerides Drugs 0.000 claims description 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 3
- 239000002245 particle Substances 0.000 description 8
- 241000186660 Lactobacillus Species 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 229940039696 lactobacillus Drugs 0.000 description 7
- 230000000813 microbial effect Effects 0.000 description 5
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000015140 cultured milk Nutrition 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 241000451942 Abutilon sonneratianum Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000202221 Weissella Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/26—Homogenisation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
Abstract
Description
본 발명은 유산균 사균체를 함유하는 투명한 생수음료의 제조방법에 관한 것이다. 보다 상세하게는 엔테로코쿠스 페칼리스 EF-2001(Enterococcus faecalis EF-2001) 유산균 사균체를 함유하는 투명한 생수음료의 제조방법에 관한 것이다.The present invention relates to a method for producing a transparent bottled beverage containing lactic acid bacteria microorganisms. More specifically, the present invention relates to a method for producing a transparent bottled water beverage containing Enterococcus faecalis EF-2001 lactic acid bacteria microorganisms.
일반적으로, 유산균은 오래 전부터 버터, 치즈와 같은 유가공 식품에서 중요한 역할을 담당하고 있으며, 유산균을 이용한 발효 식품은 특유의 풍미와 생성된 유산에 의한 우수한 보존성, 단백질의 부분 분해에 의한 소화 흡수성 향상 등 기호적, 영양적인 우수성을 나타내며 전세계를 통하여 엄청난 시장 규모를 형성하고 있다.In general, lactic acid bacteria have played an important role in dairy foods such as butter and cheese for a long time, and fermented foods using lactic acid bacteria have a distinctive flavor, excellent preservation by the resulting lactic acid, and improved digestive absorption by partial decomposition of proteins. It represents palatial and nutritional excellence and forms a huge market size throughout the world.
특히, 장내 정상 세균총의 유지, 장내 이상 발효의 개선, 장내 부패균에 의해 생성되는 독성물질의 무독화작용, 칼슘의 흡수 촉진 등 유산균의 여러가지 기능적 작용과 변비, 고혈압, 피부염, 위장염 등의 증상에 효과가 밝혀짐으로써, 국내에서는 1971년 국내 업체에서 액상 발효유 생산을 시작으로 다양한 제품이 개발되어 왔다. 특히, 근래에는 다양한 유산균주에 대한 연구가 시작되면서, 유제품 외에 콩이나 야채 등의 식물성 원료를 발효한 유산균 음료가 개발되어 제품화되고 있다. 또한, 소득수준이 높아짐에 따라 건강에 대한 관심이 높아지고 있고, 이에 유산균 발효유 또는 유산균 함유 음료 등이 소비자로부터 크게 각광받고 있다. In particular, it is effective for various functional effects of lactic acid bacteria such as maintenance of normal intestinal flora in the intestine, improvement of intestinal abnormal fermentation, detoxification of toxic substances produced by intestinal rot bacteria, promotion of absorption of calcium, and symptoms of constipation, hypertension, dermatitis, gastroenteritis. As it turns out, a variety of products have been developed in Korea in 1971 starting with the production of liquid fermented milk in domestic companies. In particular, recently, as research on various lactic acid strains has been started, lactic acid bacteria beverages fermented from vegetable raw materials such as beans and vegetables, in addition to dairy products, have been developed and commercialized. In addition, as the income level increases, interest in health is increasing, and thus, lactic acid bacteria fermented milk or a beverage containing lactic acid bacteria is greatly attracted by consumers.
대한민국 등록특허 제10-0185250호 및 대한민국 등록특허 제10-1217917호에서는 유산균을 함유하는 과채음료 및 그 제조방법에 대하여 개시되어 있으나, 생수음료 조성물이 아니라 과채음료에 관한 것이다. 기존의 유산균 함유 음료는 유제품 또는 과채음료와 같이 백탁 또는 색을 첨가한 유색의 음료 형태를 띤 것으로, 기능적 특성이 우수한 유산균 사균체를 일정량 함유하면서도 외관은 생수와 같이 투명하여 기능적, 관능적인 조건을 모두 만족시킬 수 있는 새로운 형태의 생수음료 개발을 모색할 필요가 있다.Republic of Korea Patent No. 10-0185250 and Republic of Korea Patent No. 10-1217917 discloses a fruit drink containing a lactic acid bacterium and a method for producing the same, but relates to a fruit drink not a bottled beverage composition. Existing lactobacillus-containing beverages are white, colored or colored beverages like dairy or fruit drinks.They contain a certain amount of lactic acid bacteria that have excellent functional characteristics, but their appearance is transparent like bottled water. There is a need to find new forms of bottled beverages that will satisfy all.
본 발명의 목적은 유산균 사균체를 함유하는 투명한 생수음료의 제조방법을 제공하는 것이다. 보다 구체적으로는 엔테로코쿠스 페칼리스 EF-2001(Enterococcus faecalis EF-2001) 유산균 사균체를 함유하며, 고속균질 및 고압균질 처리하여 투명한 생수음료의 제조방법을 제공하는데 있다.An object of the present invention is to provide a method for producing a transparent bottled beverage containing lactic acid bacteria microorganisms. More specifically, Enterococcus faecalis EF-2001 (Enterococcus faecalis EF-2001) containing lactic acid bacteria microorganisms, and provides a method for producing a transparent bottled beverage by high-speed homogeneous and high-pressure homogeneous treatment.
상기한 바와 같은 목적을 달성하기 위하여, (a) 유산균 사균체를 1 내지 10 g/mL의 농도로 증류수에 희석하는 단계; (b) 단계 (a)에서 준비된 희석액을 중쇄트리글리세리드(medium chain triglyceride)와 혼합하는 단계; (c) 단계 (b)에서 준비된 혼합액에 1차 유화제를 혼합하는 단계; (d) 단계 (c)에서 준비된 혼합액을 고속균질 처리하여 예비-유화액(pre-emulsion)을 준비하는 단계; (e) 단계 (d)에서 준비된 예비-유화액을 고압균질 처리하여 생수음료 제조를 위한 유화액(emulsion)을 준비하는 단계; (f) 단계 (e)에서 준비된 유화액에 증류수 및 2차 유화제를 첨가하고 균질화하는 단계;를 포함하는 유산균 사균체를 함유하는 투명한 생수음료의 제조방법을 제공한다.In order to achieve the above object, (a) dilution of lactic acid bacteria microorganisms in distilled water at a concentration of 1 to 10 g / mL; (b) mixing the dilution prepared in step (a) with medium chain triglycerides; (c) mixing the primary emulsifier into the mixed liquid prepared in step (b); (d) homogenizing the mixed solution prepared in step (c) to prepare a pre-emulsion; (e) high pressure homogeneous treatment of the pre-emulsion prepared in step (d) to prepare an emulsion for the preparation of bottled beverages; (f) adding distilled water and a secondary emulsifier to the emulsion prepared in step (e) and homogenizing; provides a method for producing a transparent bottled beverage containing lactic acid bacteria microorganisms.
또한, 본 발명의 또 다른 목적을 달성하기 위하여, 상기의 방법으로 제조된 유산균 사균체를 함유하는 투명한 생수음료를 제공한다.In addition, in order to achieve another object of the present invention, there is provided a transparent bottled beverage containing lactic acid bacteria microorganisms produced by the above method.
본 발명의 유산균 사균체를 함유하는 투명한 생수음료의 제조방법은 기능적 특성이 우수한 엔테로코쿠스 페칼리스 EF-2001(Enterococcus faecalis EF-2001) 유산균 사균체를 함유하면서 최적화된 유화제 비율 및 균질 처리에 의해 탁도가 낮은 투명한 생수음료를 제조할 수 있는 방법을 제공하여 기능적, 관능적으로 우수한 효과를 갖는 생수음료의 제조를 가능하게 한다The method for preparing a transparent bottled water beverage containing lactic acid bacteria microorganisms of the present invention is characterized in that it contains an Enterococcus faecalis EF-2001 (Enterococcus faecalis EF-2001) lactic acid bacteria microorganism having excellent functional properties, and by an optimized emulsifier ratio and homogeneous treatment. By providing a method for producing a transparent turbid beverages with low turbidity, it is possible to prepare a bottled beverage having a functional and sensory excellent effect
도 1은 폴리글리세롤 폴리리시놀리에이트(PGPR) 첨가 비율에 따라 예비-유화액(pre-emulsion)의 유화안정지수(ESI)를 측정한 결과를 나타낸 도이다.
도 2는 Nanophox particle size analyzer (NX0070, Sympatec GmbH, Germany)를 이용하여 예비-유화액을 고압균질 처리군(HP) 및 고속균질 처리군(HS)으로 처리했을 때, 입도 분포를 측정한 결과를 나타낸 도이다.
도 3은 희석 비율에 따른 탁도의 변화를 알아보기 위하여 PSML의 첨가 비율은 고정하고, 증류수에 유산균 사균체 유화액의 희석 비율을 (a) 1:1,000, (b) 1:10,000, (c) 1:20,000으로 희석한 것 및 (d) 기존 제품(칼피스의 유산균 水 plus, 일본 아사히 제조 제품)의 탁도를 유관상 비교한 사진을 나타낸 도이다.1 is a diagram showing the results of measuring the emulsion stability index (ESI) of the pre-emulsion according to the polyglycerol polyricinoleate (PGPR) addition ratio.
Figure 2 shows the results of measuring the particle size distribution when the pre-emulsion was treated with a high pressure homogeneous treatment group (HP) and a high speed homogeneous treatment group (HS) using a Nanophox particle size analyzer (NX0070, Sympatec GmbH, Germany) It is also.
Figure 3 is fixed to the addition of PSML in order to determine the change in turbidity according to the dilution ratio, dilution ratio of lactic acid bacteria microbial emulsion in distilled water (a) 1: 1,000, (b) 1: 10,000, (c) 1 It is a figure which shows the photometric comparison of the turbidity of the thing diluted with 20,000 and (d) Calpis acid lactobacillus water plus, the product made by Asahi Japan.
본 발명은 (a) 유산균 사균체를 1 내지 10 g/mL의 농도로 증류수에 희석하는 단계; (b) 단계 (a)에서 준비된 희석액을 중쇄트리글리세리드(medium chain triglyceride)와 혼합하는 단계; (c) 단계 (b)에서 준비된 혼합액에 1차 유화제를 혼합하는 단계; (d) 단계 (c)에서 준비된 혼합액을 고속균질 처리하여 예비-유화액(pre-emulsion)을 준비하는 단계; (e) 단계 (d)에서 준비된 예비-유화액을 고압균질 처리하여 생수음료 제조를 위한 유화액(emulsion)을 준비하는 단계; (f) 단계 (e)에서 준비된 유화액에 증류수 및 2차 유화제를 첨가하고 균질화하는 단계;를 포함하는 유산균 사균체를 함유하는 투명한 생수음료의 제조방법을 제공한다.The present invention comprises the steps of: (a) diluting lactic acid bacteria microorganisms in distilled water at a concentration of 1 to 10 g / mL; (b) mixing the dilution prepared in step (a) with medium chain triglycerides; (c) mixing the primary emulsifier into the mixed liquid prepared in step (b); (d) homogenizing the mixed solution prepared in step (c) to prepare a pre-emulsion; (e) high pressure homogeneous treatment of the pre-emulsion prepared in step (d) to prepare an emulsion for the preparation of bottled beverages; (f) adding distilled water and a secondary emulsifier to the emulsion prepared in step (e) and homogenizing; provides a method for producing a transparent bottled beverage containing lactic acid bacteria microorganisms.
상기 유산균 사균체는 생균의 유산균을 사균화 처리한 것을 의미하며, 동결건조한 분말 형태인 것이 바람직하지만 이에 한정되지 않는다.The lactic acid bacteria microorganism means that the lactic acid bacteria of live bacteria are sterilized, preferably in the form of lyophilized powder, but is not limited thereto.
상기 유산균은 스트렙토코커스(Streptococcus) 속, 락토코커스(Lactococcus) 속, 엔테로코커스(Enterococcus) 속, 락토바실러스(Lactobacillus) 속, 페디오코커스(Pediococcus) 속, 류코노스톡(Leuconostoc) 속, 바이셀라(Weissella) 속 및 비피도박테리움(Bifidobacterium) 속으로 이루어진 군에서 선택된 하나 이상의 균주일 수 있으나 이에 한정하지 않으며, 바람직하게는 엔테로코쿠스 페칼리스 EF-2001(Enterococcus faecalis EF-2001) 유산균이며, ㈜한국베름(Seoul, Korea)에서 생산 및 판매를 하고 있는 것으로 용이하게 입수가능하다.The lactic acid bacteria are Streptococcus genus, Lactococcus genus, Enterococcus genus, Lactobacillus genus, Pediococcus genus, Licoconostoc genus, bisella Weissella) and Bifidobacterium genus (Bifidobacterium) may be one or more strains selected from the group consisting of, but not limited to, preferably enterococcus faecalis EF-2001 (Enterococcus faecalis EF-2001) lactic acid bacteria, It is produced and sold in Seoul, Korea, and is easily available.
상기 생수음료는 식용으로 음용 가능한 물 음료를 의미한다.The bottled water means a water drink that is drinkable for food.
상기 (b) 단계의 희석액 및 중쇄글리세리드(medium chain triglyceride, MCT)의 혼합은 그 혼합비가 1:5 내지 1:15일 수 있으나 이에 한정하지 않으며, 바람직하게는 1:9일 수 있다.Mixing of the diluent of step (b) and medium chain triglyceride (MCT) may be a mixing ratio of 1: 5 to 1:15, but is not limited thereto, and may be 1: 9.
상기 단계 (c)의 1차 유화제는 폴리글리세롤 폴리리시놀리에이트(polyglycerol polyricinoleate, PGPR)일 수 있으나 이에 한정하지 않는다. 상기 폴리글리세롤 폴리리시놀리에이트의 첨가량은 0.75 내지 1.0 %(W/V)인 것이 바람직하나 이에 한정하지 않는다.The primary emulsifier of step (c) may be polyglycerol polyricinoleate (PGPR), but is not limited thereto. The amount of the polyglycerol polyricinoleate added is preferably 0.75 to 1.0% (W / V), but is not limited thereto.
상기 단계 (d)에서 고속균질은 고속균질기를 이용하여 10,000 내지 15,000 rpm에서 3 내지 7분 동안 처리하는 것이 바람직하나 이에 한정하지 않는다.In the step (d), the high speed homogenizer is preferably treated for 3 to 7 minutes at 10,000 to 15,000 rpm using a high speed homogenizer, but is not limited thereto.
상기 단계 (e)에서 고압균질은 고압균질기를 이용하여 18,000 내지 20,000 psi 압력 하에서 3 내지 7 사이클(cycle) 처리하는 것이 바람직하나 이에 한정하지 않는다.In the step (e), the high pressure homogenizer is preferably treated with 3 to 7 cycles under 18,000 to 20,000 psi pressure using a high pressure homogenizer, but is not limited thereto.
상기 단계 (f)의 2차 유화제는 폴리에틸렌 소르비탄 모노라우레이트(polyoxyethylene sorbitan monolaurate, PSML)일 수 있으나, 이에 한정하지 않는다. 상기 폴리에틸렌 소르비탄 모노라우레이트의 첨가량은 0.75 내지 1.0 %(W/V)인 것이 바람직하나 이에 한정하지 않는다.The secondary emulsifier of step (f) may be polyethylene sorbitan monolaurate (PSML), but is not limited thereto. The amount of the polyethylene sorbitan monolaurate added is preferably 0.75 to 1.0% (W / V), but is not limited thereto.
상기 단계 (f)에서 균질화는 고속균질기를 이용하여 5,000 내지 7,500 rpm 에서 0.5 내지 2분 동안 처리하는 것이 바람직하나 이에 한정하지 않는다.In step (f), the homogenization is preferably performed at 5,000 to 7,500 rpm for 0.5 to 2 minutes using a high speed homogenizer, but is not limited thereto.
또한, 본 발명은 상기의 방법으로 제조된 유산균 사균체를 함유하는 투명한 생수음료를 제공한다.The present invention also provides a transparent bottled beverage containing lactic acid bacteria microorganisms produced by the above method.
상기 생수음료에는 필요에 따라 관능적 특성 향상을 목적으로 음료 조성물에 통상적으로 사용할 수 있는 적정량의 향료 또는 감미료와 같은 식품첨가물이 첨가될 수 있다.If necessary, food additives such as flavors or sweeteners can be added to the bottled beverage in an appropriate amount for the purpose of improving sensory properties.
이하, 본 발명의 실시예를 들어 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the embodiment of the present invention will be described in detail. However, the following examples are merely to illustrate the invention, but the content of the present invention is not limited to the following examples.
하기 실험을 통해 얻은 데이터는 SAS 9.4를 이용하여 ANOVA test를 실시하였고, LSD를 이용하여 5% 유의 수준에서 대조군과 실험군 간의 유의성 검정을 실시하였다. The data obtained through the following experiment was performed ANOVA test using SAS 9.4, and significance test between the control group and the experimental group was performed at 5% significance level using LSD.
<< 실시예Example 1> 유산균 1> Lactobacillus 사균체를Dead cells 포함하는 Containing 생수음료의Bottled water 제조 Produce
유산균 사균체는 ㈜한국베름(Seoul, Korea)에서 제공받았으며, 엔테로코쿠스 페칼리스 EF-2001(Enterococcus faecalis EF-2001) 7.5×1012 CFU/g의 유산균 사균체를 함유한다. Lactobacillus microorganisms were provided by Berlin, Korea and contain lactic acid bacteria microorganisms of 7.5 × 10 12 CFU / g of Enterococcus faecalis EF-2001.
상기 유산균 사균체는 5 g/mL의 농도로 증류수에 희석하여 준비하였다. The lactic acid bacteria microorganisms were prepared by diluting in distilled water at a concentration of 5 g / mL.
준비된 유산균 사균체 희석액과 중쇄글리세리드(MCT)를 1:9의 비율로 혼합하였다. 혼합한 후, 상기 혼합액에 0.75 %(W/V)의 폴리글리세롤 폴리리시놀리에이트(PGPR)를 혼합하고, 고속균질기(Ultra-Turrax T20, Ika-Werke GmbH, Germany)를 이용하여 13,500 rpm에서 5분 동안 균질 처리하여 예비-유화액(pre-emulsion)을 제조하였다. 준비된 예비-유화액을 고압균질기(Picomax MN-400, Micronox Co., Korea)를 이용하여 20,000 psi의 압력에서 6 cycle 고압균질 처리하여, 생수음료 제조를 위한 유화액(emulsion)을 제조하였다. The prepared lactic acid bacteria microbial diluent and medium chain glycerides (MCT) were mixed at a ratio of 1: 9. After mixing, 0.75% (W / V) of polyglycerol polylysinoleate (PGPR) was mixed with the mixed solution, using a high speed homogenizer (Ultra-Turrax T20, Ika-Werke GmbH, Germany) at 13,500 rpm. Pre-emulsion was prepared by homogenizing for 5 minutes. The prepared pre-emulsion was subjected to 6 cycle high pressure homogenization at a pressure of 20,000 psi using a high pressure homogenizer (Picomax MN-400, Micronox Co., Korea), to prepare an emulsion for the preparation of bottled beverages.
상기의 방법으로 제조된 유화액에 증류수 및 1.0 %(W/V)의 폴리에틸렌 소르비탄 모노라우레이트(PSML)를 첨가하고, 6,500 rpm의 속도로 1분 동안 균질 처리하여 투명한 생수음료를 제조하였다.Distilled water and 1.0% (W / V) polyethylene sorbitan monolaurate (PSML) were added to the emulsion prepared by the above method, and homogeneous treatment was performed at a speed of 6,500 rpm for 1 minute to prepare a transparent bottled beverage.
<< 실시예Example 2> 1차 유화제( 2> primary emulsifier ( PGPRPGPR )의 첨가 비율 결정을 위한 유화안정지수(Emulsification Stability Index for Determination of Addition Rate ESIESI )의 측정) Measurement
유화액 제조를 위한 1차 유화제 첨가 비율을 결정하기 위하여, 예비-유화액의 유화안정지수를 측정하였다. 증류수에 희석된 유산균 사균체에 중쇄글리세리드(MCT)를 1:9(유산균 사균체 : MCT)의 비율로 혼합하고, 이때 폴리글리세롤 폴리리시놀리에이트(PGPR)를 각각 0.25, 0.50, 0.75, 1.00 %(W/V)의 양으로 혼합하여, 고속균질 처리하였다. 상기와 같이 제조된 유산균 사균체 예비-유화액을 55˚C 인큐베이터에 3시간 동안 방치한 후, 층분리를 관찰하였다. In order to determine the primary emulsifier addition ratio for the emulsion preparation, the emulsion stability index of the pre-emulsion was measured. Medium chain glycerides (MCT) were mixed in a ratio of 1: 9 (lactic acid bacteria microorganisms: MCT) to lactic acid bacteria microorganisms diluted in distilled water, and polyglycerol polyricinoleate (PGPR) was 0.25, 0.50, 0.75, and 1.00%, respectively. The mixture was mixed in the amount of (W / V) and subjected to high speed homogeneous treatment. The lactic acid bacteria microbial pre-emulsion prepared as described above was left in a 55 ° C. incubator for 3 hours, and then layer separation was observed.
ESI는 하기와 같이 계산하였다.ESI was calculated as follows.
ESI (%)={1-Vs/Va}×100ESI (%) = {1-Vs / Va} × 100
여기서, Va는 예비-유화액의 총 부피, Vs는 55˚C에서 3시간 동안 분리된 층의 부피를 나타낸다.Where Va is the total volume of the pre-emulsion, Vs is the volume of the layer separated for 3 hours at 55 ° C.
폴리글리세롤 폴리리시놀리에이트(PGPR)의 첨가 비율에 따른 유화안정지수의 변화에 따른 결과를 도 1에 나타내었다.The results of the change in the emulsion stability index according to the addition ratio of polyglycerol polyricinoleate (PGPR) are shown in FIG.
도 1에 나타난 바와 같이, 폴리글리세롤 폴리리시놀리에이트(PGPR)의 첨가비율이 증가함에 따라 ESI가 점차 증가하는 경향을 보였으나, 0.75와 1.00 %(W/V) 간에 유의적 차이는 존재하지 않았다(p<0.05). 따라서, 예비-유화액 제조시 첨가되는 폴리글리세롤 폴리리시놀리에이트(PGPR)의 비율은 0.75 %(W/V)으로 결정하였다.As shown in FIG. 1, the ESI tended to increase gradually as the addition ratio of polyglycerol polyricinoleate (PGPR) increased, but there was no significant difference between 0.75 and 1.00% (W / V). (p <0.05). Therefore, the proportion of polyglycerol polylysinoleate (PGPR) added in the preparation of the pre-emulsion was determined to be 0.75% (W / V).
<< 실시예Example 3> 유산균 3> Lactobacillus 사균체Dead body 예비-유화액(pre-emulsion)의 입도 분포(particle size distribution) 측정 Measurement of particle size distribution of pre-emulsion
유산균 사균체 예비-유화액의 입도 분포(particle size distribution)를 측정하기 위하여, 예비-유화액을 20,000 psi의 압력 하에서 6 cycle 처리한 고압균질 처리군(HP)과 13,500 rpm 하에서 5분 동안 처리한 고속균질 처리군(HS)으로 나누어 헵테인(heptane)에 분산시킨 후, 5분 동안 초음파 처리(sonication)하였다. 그 후 입자 크기 분석기(NX0070, Sympatec GmbH, Germany)를 이용하여 고압균질 처리군(HP) 및 고속균질 처리군(HS)의 입도 분포(particle size distribution)를 측정하였으며, 그 결과를 도 2에 나타내었다. In order to measure the particle size distribution of the lactic acid bacteria pre-emulsion, high-pressure homogeneous treatment (HP) in which the pre-emulsion was treated 6 cycles under a pressure of 20,000 psi (HP) and high-speed homogenization for 5 minutes under 13,500 rpm After dividing into the treatment group (HS) in heptane (heptane), it was sonicated for 5 minutes. Thereafter, particle size distributions of the high pressure homogeneous treatment group (HP) and the high speed homogeneous treatment group (HS) were measured using a particle size analyzer (NX0070, Sympatec GmbH, Germany), and the results are shown in FIG. 2. It was.
도 2에 나타낸 바와 같이, 고압균질 처리군(HP)과 고속균질 처리군(HS) 모두 정규분포 곡선과 같은 매끄럽고 예리한 곡선을 나타내어 입도 분포가 고른 것을 알 수 있었다. 두 가지 군의 사이즈(D4,3)를 비교해보면, 고압균질 처리군(HP)과 고속균질 처리군(HS)이 각각 177.41 및 258.88 nm을 나타내었다. 따라서, 고압균질 처리군이 고속균질 처리군에 비해 더 작은 입도 분포를 보임을 확인하였다.As shown in FIG. 2, both the high pressure homogeneous treatment group (HP) and the high speed homogeneous treatment group (HS) showed smooth and sharp curves such as a normal distribution curve, and thus the particle size distribution was uniform. Comparing the size of the two groups (D 4,3 ), the high pressure homogeneous treatment group (HP) and the high speed homogeneous treatment group (HS) showed 177.41 and 258.88 nm, respectively. Therefore, it was confirmed that the high pressure homogeneous treatment group showed a smaller particle size distribution than the high speed homogeneous treatment group.
<< 실시예Example 4> 탁도 측정 4> Turbidity Measurement
4-1. 유산균 4-1. Lactobacillus 사균체Dead body 예비-유화액(pre-emulsion)의 균질방법에 따른 According to the homogeneous method of pre-emulsion 생수음료Bottled water 탁도의 차이 Turbidity Difference
생수음료의 탁도는 분광광도계(spectrophotometer)를 이용하여 450 nm 파장에서 흡광도를 측정하였다. 이때 작은 값을 가질수록 빛의 투과도가 좋은 것이므로 탁도가 낮은 것으로(즉, 투명도가 높은 것으로) 하였으며, 탁도를 측정한 결과를 표 1에 나타내었다.Turbidity of the bottled water was measured at 450 nm wavelength using a spectrophotometer. In this case, the smaller the value, the better the light transmittance, so the turbidity was lower (that is, the higher the transparency). Table 1 shows the results of measuring the turbidity.
고압균질 또는 고속균질 처리한 유산균 사균체 예비-유화액을 각각 1:10,000, 1:20,000의 비율로 희석하여, 탁도를 측정하였다. 표 1에 나타낸 바와 같이, 고압균질 처리군(HP)이 고속균질 처리군(HS)에 비해 유의적으로 투명도가 높게 나타났으며(p<0.05), 고압균질 처리군(HP)의 경우에는 1:10,000과 1:20,000 간에 투명도에서 유의적인 차이가 나타나지 않았음에 비해(p<0.05), 고속균질 처리군(HS)의 경우, 1:20,000 이 1:10,000에 비해 투명도가 유의적으로 더 높게 나타났음을 확인하였다(p<0.05).High-pressure homogeneous or high-speed homogeneous lactic acid bacteria pre-emulsion was diluted at a ratio of 1: 10,000 and 1: 20,000, respectively, and turbidity was measured. As shown in Table 1, the high pressure homogeneous treatment group (HP) was significantly higher in transparency than the high speed homogeneous treatment group (HS) (p <0.05). Compared to: 10,000 and 1: 20,000, there was no significant difference in transparency (p <0.05), but in the high speed homogeneous treatment group (HS), 1: 20,000 was significantly higher than 1: 10,000 in transparency. It was confirmed that it appeared (p <0.05).
1Values with different superscripts in acolumn (a-b) and row (A-B) are significant at p<0.05. 1 Values with different superscripts in acolumn (ab) and row (AB) are significant at p <0.05.
4-2. 폴리에틸렌 4-2. Polyethylene 소르비탄Sorbitan 모노라우레이트Monolaurate (( PSMLPSML ) 첨가 비율에 따른 탁도의 변화) Changes in Turbidity with Addition Rate
생수음료 제조시 폴리에틸렌 소르비탄 모노라우레이트(PSML)의 첨가 비율에 따른 탁도의 변화를 측정한 결과를 표 2에 나타내었다. Table 2 shows the results of measuring the change in turbidity according to the ratio of the addition of polyethylene sorbitan monolaurate (PSML) in the preparation of bottled beverages.
표 2에 나타난 바와 같이, PSML의 첨가 비율이 늘어남에 따라 투명도가 높아지는 경향을 확인할 수 있으며, 각 처리군 간에 유의적인 차이가 존재함을 확인하였다(p<0.05). 상기 결과에 따라 PSML의 첨가 비율은 1.00 %(W/V)로 결정하였다.As shown in Table 2, as the addition ratio of PSML increases, the transparency tends to increase, and it was confirmed that a significant difference exists between treatment groups (p <0.05). According to the result, the addition ratio of PSML was determined to be 1.00% (W / V).
1Values with different suspects are significant at p<0.05. 1 Values with different suspects are significant at p <0.05.
4-3. 희석 비율에 따른 탁도의 변화4-3. Turbidity Variation with Dilution Ratio
희석 비율에 따른 탁도의 변화를 알아보기 위하여 PSML의 첨가 비율은 고정하고, 증류수에 유산균 사균체 유화액의 희석 비율을 1:1,000, 1:10,000, 1:20,000으로 희석한 후 비커 용기에 담아 유관상 비교한 사진을 도 3에 나타내었다.In order to determine the change in turbidity according to the dilution ratio, the addition ratio of PSML was fixed, and the dilution ratio of the lactic acid bacteria microbial emulsion in distilled water was diluted 1: 1,000, 1: 10,000, 1: 20,000, and placed in a beaker container. The comparative photograph is shown in FIG.
도 3에 나타난 바와 같이, 유화액의 희석 비율을 (a) 1:1,000으로 처리한 것에 비해 (b) 1:10,000으로 처리한 경우 탁도가 낮아졌음을 유관상으로도 쉽게 확인할 수 있었으며, 유화액의 희석 비율이 (b) 1:10,000으로 처리한 것에 비해 (c) 1:20,000으로 처리한 경우에 탁도가 더 낮아지고 유화액이 투명해졌음을 유관상으로 확인하였다. 유화액의 희석비율을 (c) 1:20,000으로 처리한 것과 (d) 기존 제품(칼피스의 유산균 水 plus, 일본 아사히 제조 제품)과는 유관상으로는 탁도의 차이가 구별되지 않았다.As shown in FIG. 3, when the dilution ratio of the emulsion was treated with (a) 1: 1,000, the turbidity was easily lowered when treated with (b) 1: 10,000. It was confirmed in a correlated manner that the ratio was lower in turbidity and the emulsion became clear when the ratio was treated with (c) 1: 20,000 compared to the treatment with (b) 1: 10,000. The turbidity difference was not distinguished from the dilution ratio of the emulsion at (c) 1: 20,000 and (d) the existing product (Lupis lactic acid bacteria plus Calpis, manufactured by Asahi, Japan).
추가적으로, PSML의 첨가 비율은 고정하고, 증류수에 유산균 사균체 유화액의 희석 비율을 1:10,000, 1:20,000, 1:30,000으로 희석하여 450 nm 파장에서 흡광도를 측정하였으며, 기존 제품(칼피스의 유산균 水 plus, 일본 아사히 제조 제품)과 탁도를 비교한 결과를 표 3에 나타내었다. In addition, the addition ratio of PSML was fixed, and the dilution ratio of lactic acid bacteria microbial emulsion in distilled water was diluted 1: 10,000, 1: 20,000, 1: 30,000 and absorbance was measured at 450 nm. plus, Japanese Asahi Co., Ltd.) and turbidity is shown in Table 3.
표 3에 나타난 바와 같이, 희석 비율을 1:10,000에서 1:30,000으로 증가시킴에 따라 투명도는 유의적으로 증가하였으며(p<0.05), 1:30,000의 경우 기존의 일본 아사히 제품의 투명도보다 유의적으로 투명도가 높음을 확인하였다(p<0.05).As shown in Table 3, the transparency increased significantly as the dilution ratio was increased from 1: 10,000 to 1: 30,000 (p <0.05), and in the case of 1: 30,000, the transparency was significantly higher than that of conventional Japanese Asahi products. The transparency was confirmed to be high (p <0.05).
1Values with different suspects are significant at p<0.05. 1 Values with different suspects are significant at p <0.05.
이상 본 발명자에 의해서 이루어진 발명을 상기 실시예에 따라 구체적으로 설명하였다. 다만, 상기의 실시예는, 본 발명의 내용을 예시하는 것일 뿐 발명의 범위가 상기 실시예에 한정되는 것은 아니며, 해당 기술분야의 통상의 지식을 가진 자에 의해 발명의 요지를 이탈하지 않는 범위에서 변경 가능한 것으로 이해되어야 한다.The invention made by the inventor has been described in detail according to the above embodiment. However, the above embodiments are merely to exemplify the contents of the present invention, and the scope of the present invention is not limited to the above embodiments, and the scope does not depart from the gist of the invention by those skilled in the art. It is to be understood that the present invention is changeable at.
Claims (11)
(b) 단계 (a)에서 준비된 희석액을 중쇄트리글리세리드(medium chain triglyceride)와 혼합하는 단계;
(c) 단계 (b)에서 준비된 혼합액에 1차 유화제를 혼합하는 단계;
(d) 단계 (c)에서 준비된 혼합액을 고속균질 처리하여 예비-유화액(pre-emulsion)을 준비단계;
(e) 단계 (d)에서 준비된 예비-유화액을 고압균질 처리하여 생수음료 제조를 위한 유화액(emulsion)을 준비하는 단계;
(f) 단계 (e)에서 준비된 유화액에 증류수 및 2차 유화제를 첨가하고 균질화하는 단계;를 포함하는
유산균 사균체를 함유하는 투명한 생수음료의 제조방법.
(a) diluting lactic acid bacteria microorganisms in distilled water at a concentration of 1 to 10 g / mL;
(b) mixing the dilution prepared in step (a) with medium chain triglycerides;
(c) mixing the primary emulsifier into the mixed liquid prepared in step (b);
(d) homogenizing the mixed solution prepared in step (c) to prepare a pre-emulsion;
(e) high pressure homogeneous treatment of the pre-emulsion prepared in step (d) to prepare an emulsion for the preparation of bottled beverages;
(f) adding and homogenizing distilled water and a secondary emulsifier to the emulsion prepared in step (e);
A method for producing a transparent bottled water beverage containing lactic acid bacteria microorganisms.
상기 (a) 단계의 유산균 사균체는 엔테로코쿠스 페칼리스 EF-2001(Enterococcus faecalis EF-2001) 유산균 사균체인 것을 특징으로 하는 유산균 사균체를 함유하는 투명한 생수음료의 제조방법.
The method according to claim 1,
The lactic acid bacteria microorganism of step (a) is Enterococcus faecalis EF-2001 (Enterococcus faecalis EF-2001) lactic acid bacteria microorganisms characterized in that the production method of a transparent bottled water containing lactic acid bacteria microorganisms.
상기 (b) 단계의 희석액 및 중쇄글리세리드의 혼합은 그 혼합비가 1:9인 것을 특징으로 하는 유산균 사균체를 함유하는 투명한 생수음료의 제조방법.
The method according to claim 1,
Mixing of the dilution of the step (b) and medium chain glycerides is a method for producing a transparent bottled water containing lactic acid bacteria microorganism characterized in that the mixing ratio is 1: 9.
상기 단계 (c)의 1차 유화제는 폴리글리세롤 폴리리시놀리에이트(polyglycerol polyricinoleate) 0.75 내지 1.0 %(W/V)인 것을 특징으로 하는 유산균 사균체를 함유하는 투명한 생수음료의 제조방법.
The method according to claim 1,
The primary emulsifier of step (c) is polyglycerol polyricinoleate (polyglycerol polyricinoleate) 0.75 to 1.0% (W / V) method for producing a transparent bottled water containing lactic acid bacteria microorganisms.
상기 단계 (d)에서 고속균질은 고속균질기를 이용하여 10,000 내지 15,000 rpm에서 3 내지 7분 동안 처리한 것을 특징으로 하는 유산균 사균체를 함유하는 투명한 생수음료의 제조방법.
The method according to claim 1,
The high speed homogeneity in step (d) is a method for producing a transparent bottled water containing lactic acid bacteria microorganisms, characterized in that the treatment for 3 to 7 minutes at 10,000 to 15,000 rpm using a high speed homogenizer.
상기 단계 (e)에서 고압균질은 고압균질기를 이용하여 18,000 내지 20,000 psi 압력 하에서 3 내지 7 사이클(cycle) 처리한 것을 특징으로 하는 유산균 사균체를 함유하는 투명한 생수음료의 제조방법.
The method according to claim 1,
The high pressure homogeneity in the step (e) is a high-pressure homogenizer using a high-pressure homogenizer 3 to 7 cycles (cycle) under the pressure of 18,000 to 20,000 (cycle), characterized in that the production method of a transparent bottled water containing lactic acid bacteria microorganisms.
상기 단계 (f)의 2차 유화제는 폴리에틸렌 소르비탄 모노라우레이트(polyoxyethylene sorbitan monolaurate) 0.75 내지 1.0 %(W/V)인 것을 특징으로 하는 유산균 사균체를 함유하는 투명한 생수음료의 제조방법.
The method according to claim 1,
The secondary emulsifier of step (f) is polyethylene sorbitan monolaurate (polyoxyethylene sorbitan monolaurate) 0.75 to 1.0% (W / V) method for producing a transparent bottled water containing lactic acid bacteria microorganisms.
상기 단계 (f)에서 증류수를 희석하는 비율은 단계 (e)에서 준비된 유화액 및 증류수의 비율이 1:30,000인 것을 특징으로 하는 유산균 사균체를 함유하는 투명한 생수음료의 제조방법.
The method according to claim 1,
The ratio of diluting the distilled water in step (f) is a ratio of the emulsion prepared in step (e) and distilled water ratio of 1: 30,000, characterized in that the production method of a transparent bottled water containing lactic acid bacteria microorganisms.
상기 단계 (f)에서 균질화는 고속균질기를 이용하여 5,000 내지 7,500 rpm 에서 0.5 내지 2분 동안 처리한 것을 특징으로 하는 유산균 사균체를 함유하는 투명한 생수음료의 제조방법.
The method according to claim 1,
Homogenization in the step (f) is a method for producing a transparent bottled water containing lactic acid bacteria microorganisms, characterized in that the treatment for 0.5 to 2 minutes at 5,000 to 7,500 rpm using a high speed homogenizer.
Transparent bottled water containing lactic acid bacteria microorganisms prepared by the method of claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180043144A KR102112349B1 (en) | 2018-04-13 | 2018-04-13 | Method for manufacturing transparent water comprising heat-killed lactic acid bacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180043144A KR102112349B1 (en) | 2018-04-13 | 2018-04-13 | Method for manufacturing transparent water comprising heat-killed lactic acid bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190119774A true KR20190119774A (en) | 2019-10-23 |
KR102112349B1 KR102112349B1 (en) | 2020-05-18 |
Family
ID=68460959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180043144A KR102112349B1 (en) | 2018-04-13 | 2018-04-13 | Method for manufacturing transparent water comprising heat-killed lactic acid bacteria |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102112349B1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030070800A (en) * | 2002-02-26 | 2003-09-02 | 주식회사 국순당 | Method for preparation of dairy products containing bilayerly microencapsulated lactic acid bacteria |
KR20090067005A (en) * | 2007-12-19 | 2009-06-24 | (주)뉴트리 | Transparent emulsified composition and cosmetics or food comprising the same |
KR20160005182A (en) * | 2014-07-03 | 2016-01-14 | 건국대학교 산학협력단 | Nano-emulsion comprising cinnamon oil and method therefor |
JP2017112995A (en) * | 2015-12-18 | 2017-06-29 | アサヒ飲料株式会社 | Microbial cell-containing beverage |
-
2018
- 2018-04-13 KR KR1020180043144A patent/KR102112349B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030070800A (en) * | 2002-02-26 | 2003-09-02 | 주식회사 국순당 | Method for preparation of dairy products containing bilayerly microencapsulated lactic acid bacteria |
KR20090067005A (en) * | 2007-12-19 | 2009-06-24 | (주)뉴트리 | Transparent emulsified composition and cosmetics or food comprising the same |
KR20160005182A (en) * | 2014-07-03 | 2016-01-14 | 건국대학교 산학협력단 | Nano-emulsion comprising cinnamon oil and method therefor |
JP2017112995A (en) * | 2015-12-18 | 2017-06-29 | アサヒ飲料株式会社 | Microbial cell-containing beverage |
Also Published As
Publication number | Publication date |
---|---|
KR102112349B1 (en) | 2020-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Silva et al. | The effect of Isabel grape addition on the physicochemical, microbiological and sensory characteristics of probiotic goat milk yogurt | |
Vahedi et al. | Optimizing of fruit yoghurt formulation and evaluating its quality during storage | |
Randazzo et al. | Survival of Lactobacillus rhamnosus probiotic strains in peach jam during storage at different temperatures | |
JP5227433B2 (en) | Composition of fruit vegetable beverage containing lactic acid bacteria and method for producing the same | |
Dogahe et al. | Effect of process variables on survival of bacteria in probiotics enriched pomegranate juice | |
Jrad et al. | Potential effects of ultrafiltration process and date powder on textural, sensory, bacterial viability, antioxidant properties and phenolic profile of dromedary Greek yogurt | |
Irkin | Natural fermented beverages | |
FR2909526A1 (en) | FOOD PRODUCT COMPRISING PROBIOTICS AND A LOW PROTON MONOACIDE | |
Sumonsiri | Effect of nisin on microbial, physical, and sensory qualities of micro-filtered coconut water (Cocos nucifera L.) during refrigerated storage | |
MXPA05000868A (en) | Method for production of coconut water beverage and blended juice beverages with coconut water. | |
KR102112349B1 (en) | Method for manufacturing transparent water comprising heat-killed lactic acid bacteria | |
Nursiwi et al. | Characteristic of fermented whey beverage with addition of tomato juice (Lycopersicum esculentum) | |
Akubor | Quality characteristics and storage properties of squash prepared from pineapple (Ananas comosus) fruit juice | |
Dias et al. | Phisicochemical, sensory, and microbiological evaluation and development of symbiotic fermented drink | |
Silva et al. | Development of probiotic grape juice and Lactobacillus paracasei viability under cold storage | |
Alzahra et al. | Evaluation of Lactiplantibacillus pentosus probiotic fermented buffalo milk with citrus juice | |
KR102260678B1 (en) | Method for producing lactic acid bacterial fermentation food using fruit vegetables | |
KR20160066464A (en) | Method of Manufacturing Aronia Yogurt, and Aronia Yogurt Manufactured by the same Method | |
KR101445796B1 (en) | Egg yolk yogurt and method of preparing therefor | |
KR102140872B1 (en) | Fermented product of red beet and manufacturing method thereof | |
Costa et al. | Dairy drink fermented with chia seed and acerola syrup: physicochemical, microbiological, and sensory characterization | |
Kalantarmahdavi et al. | Viability of Lactobacillus plantarum incorporated with sourdough powder-based edible film in set yogurt and subsequent changes during post fermentation storage | |
Wend-benedo et al. | Controlled fermentation of the zoom-koom dough using two isolates of lactic acid bacteria (LAB 1 and LAB 5) as starter cultures: Effect on hygienic, rheological, nutritional and sensorial characteristics of the final product | |
Mahdavi et al. | Effect of bananas puree on survival of Lactobacillus casei in coktel apple and banana juice during storage | |
Mortazavi et al. | Production of a probiotic camel milk enriched with pomegranate peel powder. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |